Earnings Preview: Co-Diagnostics
Portfolio Pulse from Benzinga Insights
Co-Diagnostics (NASDAQ:CODX) is scheduled to release its quarterly earnings report on March 14, 2024, with an expected EPS of $-0.20. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat followed by a 10.24% drop. Shares are currently trading at $1.175, down 60.14% over the last year, indicating a bearish sentiment among long-term shareholders.
March 13, 2024 | 5:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Co-Diagnostics is expected to report an EPS of $-0.20 for the upcoming quarter. Historical data shows mixed reactions to past earnings, with a significant drop in share price following the last report.
Given the expected EPS and the historical negative reaction to past earnings, especially with the last quarter's beat followed by a significant price drop, it's likely that the stock price may face downward pressure in the short term. The overall bearish sentiment among long-term shareholders, indicated by a 60.14% decrease in share price over the last year, further supports this outlook.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100